Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>

Optimizing Doses of Ceftolozane/Tazobactam as Monotherapy or in Combination with Amikacin to Treat Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>

Carbapenem-resistant <i>Pseudomonas aeruginosa</i> (CRPA) is a hospital-acquired pathogen with a high mortality rate and limited treatment options. We investigated the activity of ceftolozane/tazobactam (C/T) and its synergistic effects with amikacin to extend the range of optimal therap...

Full description

Saved in:
Bibliographic Details
Main Authors: Worapong Nasomsong (Author), Parnrada Nulsopapon (Author), Dhitiwat Changpradub (Author), Supanun Pungcharoenkijkul (Author), Patomroek Hanyanunt (Author), Tassanawan Chatreewattanakul (Author), Wichai Santimaleeworagun (Author)
Format: Book
Published: MDPI AG, 2022-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items